UNSW Sydney’s Centre for Molecular Oncology will partner with not-for-profit cancer genomics leader Omico to deliver the national precision oncology program PrOSPeCT.
The Zero Childhood Cancer Program (ZERO) will this month begin a progressive expansion to become available to all Australians aged 0 to 18 years with cancer, by the end of the year.
Australia’s Zero Childhood Cancer program has so far identified the genetic basis of a child’s cancer in more than 90 per cent of cases, new research shows.
